# TMZ Resistance Prediction in Glioma Using Multi-Cohort Transcriptomic Data and Deep Learning

## Abstract

Temozolomide (TMZ) resistance remains a major clinical challenge in the treatment of gliomas. In this study, we develop a deep learning framework to predict TMZ response using multi-cohort transcriptomic datasets, including TCGA and CGGA. We integrate RNA-sequencing expression profiles with clinical annotations to construct biologically informed resistance labels, train a multilayer perceptron (MLP) classifier, and validate its generalizability across independent cohorts. Downstream analyses include survival modeling, differential gene expression, and pathway enrichment to identify molecular mechanisms associated with treatment resistance.

---

## 1. Introduction

Gliomas are highly aggressive brain tumors with poor prognosis and frequent resistance to chemotherapy. TMZ is the standard first-line chemotherapeutic agent; however, resistance mechanisms remain incompletely understood. This work leverages large-scale transcriptomic datasets and deep learning to:

- Predict TMZ resistance at the transcriptome level
- Identify prognostic subgroups
- Discover associated molecular pathways
- Provide interpretable biomarkers of resistance

---

## 2. Datasets

### 2.1 CGGA Cohorts
- CGGA693 RNA-seq dataset
- CGGA325 RNA-seq dataset
- Clinical annotations include:
  - TMZ treatment status
  - MGMT promoter methylation
  - Overall survival (OS)

### 2.2 TCGA Cohort
- TCGA-GBM / LGG RNA-seq expression matrix
- Clinical survival data
- Used as independent validation cohort

---

## 3. Data Processing Pipeline

### 3.1 Expression Preprocessing
- Gene-level expression alignment across cohorts
- Removal of duplicated gene entries
- Log2 transformation:  
  \[
  x' = \log_2(x + 1)
  \]
- Handling of missing values and infinite values
- Removal of low-quality gene families (e.g., pseudogenes, lncRNA subsets)

### 3.2 Gene Filtering
- Median absolute deviation (MAD) selection
- Top 3000 most variable genes retained

### 3.3 Cross-Cohort Harmonization
- Intersection of shared genes across TCGA and CGGA
- Batch-aware alignment of expression matrices

---

## 4. TMZ Resistance Label Construction

A composite biological scoring system was used:

- MGMT promoter methylation status
- Overall survival (OS)
- Gene signature-based resistance score (TR-score)

Final classification:
- **0 = TMZ Sensitive**
- **1 = TMZ Resistant**

---

## 5. Deep Learning Model

### Architecture: Multilayer Perceptron (MLP)

- Input: ~3000 gene expression features
- Dense(256) → BatchNorm → ReLU → Dropout(0.3)
- Dense(128) → BatchNorm → ReLU → Dropout(0.3)
- Dense(64) → BatchNorm → ReLU → Dropout(0.2)
- Output: Sigmoid activation

### Training Configuration
- Loss function: Binary cross-entropy
- Optimizer: Adam (lr = 1e-3)
- Regularization: L2 weight decay (1e-4)
- Evaluation: Stratified 5-fold cross-validation
- Metric: ROC-AUC

---

## 6. Model Evaluation

The model was evaluated using:

- 5-fold stratified cross-validation
- Independent TCGA validation cohort
- Metrics:
  - ROC-AUC
  - Accuracy
  - Precision, Recall, F1-score

### Key Result
The model demonstrates stable predictive performance across folds, indicating robust generalization across glioma cohorts.

---

## 7. Survival Analysis

Kaplan–Meier survival analysis was performed using predicted TMZ response groups.

- Log-rank test used to assess significance
- Comparison:
  - Predicted Resistant vs Predicted Sensitive

### Outcome
Significant survival separation between groups, indicating clinical relevance of model predictions.

---

## 8. Differential Gene Expression Analysis

- Comparison: Resistant vs Sensitive tumors
- Statistical framework: log-fold change + p-value testing
- Visualization: Volcano plots

### Key Findings
Top differentially expressed genes include:

- CLIC1
- TIMP1
- PDPN
- MMP9
- COL1A1 / COL3A1
- ANXA2P2

These genes are associated with tumor invasion, extracellular matrix remodeling, and glioma aggressiveness.

---

## 9. Functional Enrichment Analysis

### GO Biological Processes
Enriched pathways include:
- Extracellular matrix organization
- Synaptic signaling regulation
- Neural development pathways

### KEGG Pathways
- Neuroactive ligand-receptor interaction
- Nicotine addiction pathway (neuro-signaling overlap)
- AGE-RAGE signaling pathway
- Protein digestion and ECM remodeling pathways

---

## 10. Biological Interpretation

TMZ resistance in glioma is associated with:

- Extracellular matrix (ECM) remodeling
- Neuroactive signaling dysregulation
- Immune and inflammatory microenvironment activation
- Metabolic reprogramming
- Tumor invasion and adhesion pathways

These findings suggest that resistance is not only a drug-response phenotype but also a complex tumor ecosystem state.

---

## 11. Key Outputs

- TCGA TMZ resistance predictions
- Kaplan–Meier survival curves
- Volcano plots of DE genes
- GO/KEGG pathway enrichment results
- Trained MLP model for classification

---

## 12. Requirements

```bash
pip install numpy pandas scikit-learn tensorflow keras lifelines matplotlib seaborn gseapy
